See also this year's filing and all EDGAR filings for this company.
PDF Report 0001321834_2023_MyMD_Pharmaceuticals_Inc.pdf
Logs
| info | Minor missing amount for aggregate added to remainder | industry.us_generic | {'aggregate': 'Assets', 'missing_ratio': 0.4089941024350515, 'aggregate_val': 17539980, 'exp_sum': 29678181, 'exp_to_value': {'AssetsCurrent': 5401779, 'AssetsNoncurrent': 12138201, 'PropertyPlantAndEquipmentNet': 0, 'Goodwill': 10498539, 'remainder_Assets': 1639662}} |
Graph
Absolute values for 0001321834, MyMD Pharmaceuticals Inc.
| xvar | xval | |
|---|---|---|
| 0 | LiabilitiesNoncurrent | 75,941 |
| 1 | LiabilitiesCurrent | 2,768,983 |
| 2 | remainder_Liabilities | 0 |
| 3 | AssetsCurrent | 5,401,779 |
| 4 | AssetsNoncurrent | 12,138,201 |
| 5 | PropertyPlantAndEquipmentNet | 0 |
| 6 | Goodwill | 10,498,539 |
| 7 | remainder_Assets | -10,498,539 |
| 8 | GeneralAndAdministrativeExpense | 5,520,150 |
| 9 | ResearchAndDevelopmentExpense | 9,067,422 |
| 10 | remainder_Expenses | 695,191 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 85,427 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Liabilities | 2,844,924 |
| 1 | Assets | 17,539,980 |
| 2 | Expenses | 15,282,763 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 14,695,056 |
| 5 | NetIncome | -15,197,336 |
| 6 | ComprehensiveNetIncome | -15,197,336 |
| 7 | BaseVar | 17,876,547 |
| 8 | EconomicCapitalRatio | -0.266 |